When CD57+ glioma cells interact with CAR-T cells, an increase in the expression of the T cell senescence marker CD57 on CAR-T cells is observed.776 Similarly, CAR-T cells targeting the epidermal growth factor receptor variant III (EGFRvIII) have been effective in killing target cells. Here, B3GAT1 is linked to central nervous system cancer.